Resolute Advisors LLC Gilead Sciences, Inc. Transaction History

Resolute Advisors LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$64.88 - $73.64 $24,913 - $28,277	-384 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$67.69 - $73.03 $4,196 - $4,527	62 Added 19.25%	384 $27,000
Q2 2021 Dec 27, 2021	BUY	$63.47 - $69.35 $20,437 - $22,330	322 New	322 $22,000
Q2 2021 Aug 13, 2021	SELL	$63.47 - $69.35 $20,437 - $22,330	-322 Closed	0 $0
Q1 2021 Dec 27, 2021	BUY	$60.0 - $68.46 $19,320 - $22,044	322 New	322 $18,000
Q1 2021 May 17, 2021	SELL	$60.0 - $68.46 $1,500 - $1,711	-25 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$56.65 - $64.55 $1,416 - $1,613	25 New	25 $1,000

1,927

994M

10.5M

9.75M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Resolute Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Resolute Advisors LLC with notifications on news.